Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)
China · Delayed Price · Currency is CNY 10.81
-0.57 (-5.01%)
Jun 18, 2026, 3:04 PM CST
SHE:000403 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 10,274 | 13,011 | 15,448 | 19,957 | 16,669 | 20,540 | |
Market Cap Growth | -35.80% | -15.77% | -22.60% | 19.73% | -18.85% | 9.77% |
Enterprise Value | 10,355 | 12,801 | 14,283 | 18,990 | 15,725 | 19,928 |
Last Close Price | 10.81 | 13.69 | 16.00 | 20.33 | 16.91 | 20.78 |
PE Ratio | 30.38 | 31.03 | 20.73 | 32.60 | 28.39 | 52.52 |
Forward PE | 10.18 | 11.50 | 16.77 | 30.96 | 20.90 | 36.40 |
PS Ratio | 3.95 | 4.94 | 5.82 | 8.57 | 6.93 | 10.42 |
PB Ratio | 1.27 | 1.61 | 1.95 | 2.69 | 2.43 | 3.25 |
P/TBV Ratio | 1.91 | 2.43 | 3.02 | 4.34 | 4.11 | 5.85 |
P/FCF Ratio | - | - | - | 66.14 | 114.50 | 250.30 |
P/OCF Ratio | - | - | 48.01 | 29.39 | 31.80 | 50.32 |
EV/Sales Ratio | 3.98 | 4.86 | 5.38 | 8.15 | 6.54 | 10.11 |
EV/EBITDA Ratio | 16.49 | 18.39 | 15.55 | 24.64 | 22.32 | 37.04 |
EV/EBIT Ratio | 21.19 | 22.70 | 18.01 | 29.97 | 26.79 | 46.32 |
EV/FCF Ratio | - | - | - | 62.94 | 108.02 | 242.85 |
Debt / Equity Ratio | 0.10 | 0.10 | 0.08 | 0.07 | 0.05 | 0.02 |
Debt / EBITDA Ratio | 1.25 | 1.15 | 0.71 | 0.64 | 0.52 | 0.26 |
Debt / FCF Ratio | - | - | - | 1.64 | 2.57 | 1.72 |
Net Debt / Equity Ratio | 0.01 | -0.03 | -0.12 | -0.18 | -0.15 | -0.15 |
Net Debt / EBITDA Ratio | 0.14 | -0.32 | -1.03 | -1.76 | -1.49 | -1.82 |
Net Debt / FCF Ratio | -0.16 | 0.40 | 4.77 | -4.50 | -7.21 | -11.92 |
Asset Turnover | 0.28 | 0.28 | 0.30 | 0.28 | 0.32 | 0.45 |
Inventory Turnover | 0.97 | 1.09 | 1.25 | 1.46 | 1.69 | 1.80 |
Quick Ratio | 1.59 | 1.88 | 2.42 | 2.70 | 2.46 | 2.67 |
Current Ratio | 3.37 | 3.30 | 3.74 | 3.72 | 3.18 | 3.85 |
Return on Equity (ROE) | 4.39% | 5.24% | 9.71% | 8.56% | 8.91% | 10.73% |
Return on Assets (ROA) | 3.29% | 3.77% | 5.55% | 4.77% | 4.87% | 6.13% |
Return on Invested Capital (ROIC) | 5.05% | 6.38% | 10.63% | 9.48% | 9.36% | 11.15% |
Return on Capital Employed (ROCE) | 5.90% | 6.80% | 9.60% | 8.20% | 8.40% | 6.70% |
Earnings Yield | 3.44% | 3.22% | 4.83% | 3.07% | 3.52% | 1.90% |
FCF Yield | -5.30% | -4.22% | -1.29% | 1.51% | 0.87% | 0.40% |
Dividend Yield | - | - | 2.40% | 0.76% | 0.36% | 0.21% |
Payout Ratio | 77.72% | 65.30% | 35.50% | 10.91% | 8.46% | 3.08% |
Buyback Yield / Dilution | -2.33% | 0.28% | -0.88% | 0.33% | -3.38% | -44.25% |
Total Shareholder Return | -2.33% | 0.28% | 1.53% | 1.08% | -3.02% | -44.04% |